KETOFEN 10% SOLUTION FOR INJECTION

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ketofen 10 % Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, cattle
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In the horse, Ketofen 10% is indicated for:
- the alleviation of inflammation and pain associated with
musculoskeletal disorders.
- the alleviation of visceral pain associated with colic.
In cattle, Ketofen 10% is indicated for:
- the supportive treatment of parturient paresis associated with
calving;
- reducing the pyrexia and distress associated with bacterial
respiratory disease when used in connection with anti
microbial therapy as appropriate;
- reducing the clinical signs of mastitis associated with acute
endotoxin mastitis;
- improving the recovery rate in acute clinical mastitis,
caused by gram negative micro-organisms,
in conjunction with
antimicrobial therapy;
- reducing oedema of the udder associated with calving.
4.3 CONTRAINDICATIONS
Do not administer to horses or cattle that have previously shown a
hypersensitivity to ketoprofen.
Do not administer other non-steroidal anti-inflammatory drugs (NSAIDs)
concurrently or within 24 hours of each
other.
Use is contraindicated in animals suffering from cardiac, hepatic or
renal disease, where there is the possibility of gastro-
intestinal ulceration or bleeding, where there is evidence of a blood
dyscrasia or hypersensitivity to the product.
Active ingredient:
Ketoprofen
100 mg/ml
Preservative:
Benzyl alcohol
10
mg/ml
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__
                                
                                Read the complete document